testpage for testmenutable

• FDA EUA approved for saliva specimens collected in sterile cups or tubes without addition of any preservatives providing greater ease in sample collection.

• Extraction-free RT-PCR: Proteinase K heat treatment followed by real time reverse transcription polymerase chain reaction (RT-PCR) on the Applied Biosystems 7500 Fast Dx

• Utilizes combinations of alternate and substitute reagents, at each step adding redundancy and flexibility in the supply chain.

• Enables non-invasive, frequent sampling and reduces the need for trained healthcare professionals during collection

• Targets 1 region of the viral genome

• Testing Specificity: 100%
• Testing Sensitivity: 94.6% 
• FDA Emergency Use Authorization
• Healthcare Provider Fact Sheet (US)
• Patient Fact Sheet (US)

The MDL RIC test utilizes the "gold standard" for viral PCR testing. First, nucleic acid extraction is performed followed by RT-PCR that looks for multiple viruses in the sample. This test requires nasopharyngeal, oropharyngeal, or anterior nares swab placed in viral transport media. Specificity is essentially 100% and sensitivity is >97%.

• Approved for use on all CDC approved upper respiratory specimens (such as nasopharyngeal, oropharyngeal, and mid-turbinate swabs)
• The gold standard for testing: full viral RNA extraction on the KingFisher™ Flex with real-time reverse transcription polymerase chain reaction (RT-PCR) on the Applied Biosystems™ 7500 Fast Dx
• Coming soon: Addition of approved saliva specimen for infection detection
• Targets 3 different viruses
• Targets multiple regions of the COVID-19 viral genome
• Testing Specificity: 100%
• Testing Sensitivity: >97%
• Patient Information Sheet
• Healthcare Provider Information Sheet
• Partner Information Sheet